|
1
|
Selman M, King TE, Pardo A, et al:
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses
about its pathogenesis and implications for therapy. Ann Intern
Med. 134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Green FH: Overview of pulmonary fibrosis.
Chest. 122(6 Suppl): 334S–339S. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Selman M, Ruiz V, Cabrera S, et al:
TIMP-1, -2, -3 and -4 in idiopathic pulmonary fibrosis. A
prevailing nondegradative lung microenvironment? Am J Physiol Lung
Cell Mol Physiol. 279:L562–L574. 2000.PubMed/NCBI
|
|
4
|
Suga M, Iyonaga K, Okamoto T, et al:
Characteristic elevation of matrix metalloproteinase activity in
idiopathic interstitial pneumonias. Am J Respir Crit Care Med.
162:1949–1956. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nkyimbeng T, Ruppert C, Shiomi T, et al:
Pivotal role of matrix metalloproteinase 13 in extracellular matrix
turnover in idiopathic pulmonary fibrosis. PLoS One. 8:e732792013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dancer RC, Wood AM and Thickett DR:
Metalloproteinases in idiopathic pulmonary fibrosis. Eur Respir J.
38:1461–1467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagase H and Brew K: Designing TIMP
(tissue inhibitor of metalloproteinases) variants that are
selective metalloproteinase inhibitors. Biochem Soc Symp.
70:201–212. 2003.PubMed/NCBI
|
|
8
|
Wang BL, Tu YY, Fu JF, et al: Unbalanced
MMP/TIMP-1 expression during the development of experimental
pulmonary fibrosis with acute paraquat poisoning. Mol Med Rep.
4:243–248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakashima T, Yokoyama A, Onari Y, et al:
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation
and fibrosis. J Allergy Clin Immunol. 121:1269–1276. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shoda H, Yokoyama A, Nishino R, et al:
Overproduction of collagen and diminished SOCS1 expression are
causally linked in fibroblasts from idiopathic pulmonary fibrosis.
Biochem Biophys Res Commun. 353:1004–1010. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Margaritopoulos GA, Giannarakis I,
Siafakas NM and Antoniou KM: An update on idiopathic pulmonary
fibrosis. Panminerva Med. 55:109–120. 2013.PubMed/NCBI
|
|
12
|
Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M
and Yamanaka N: Localization of matrix metalloproteinases-1, -2,
and -9 and tissue inhibitor of metalloproteinase-2 in interstitial
lung diseases. Lab Invest. 78:687–698. 1998.PubMed/NCBI
|
|
13
|
Henry MT, McMahor K, Mackarel AJ, et al:
Matrix metalloproteinases and tissue inhibiter of
metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J.
20:1220–1227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McKeown S, Richter AG, O'Kane C, McAuley
DF and Thickett DR: MMP expression and abnormal lung permeability
are important determinants of outcome in IPF S. Eur Respir J.
33:77–84. 2009. View Article : Google Scholar
|
|
15
|
Kim JY, Choeng HC, Ahn C and Cho SH: Early
and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary
fibrosis. Yonsei Med J. 50:68–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ouchi H, Fujita M, Ikegame S, et al: The
role of collagenases in experimental pulmonary fibrosis. Pulm
Pharmacol Ther. 21:401–408. 2008. View Article : Google Scholar
|
|
17
|
Ramos C, Montaño M, García-Alvarez J, et
al: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs
differ in growth rate, apoptosis, and tissue inhibitor of
metalloproteinases expression. Am J Respir Cell Mol Biol.
24:591–598. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruiz V, Ordóñez RM, Berumen J, et al:
Unbalanced colla-genases/TIMP-1 expression and epithelial apoptosis
in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol.
285:L1026–L1036. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pardo A, Selman M and Kaminski N:
Approaching the degradome in idiopathic pulmonary fibrosis. Int J
Biochem Cell Biol. 40:1141–1155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koskivirta I, Rahkonen O, Mäyränpää M, et
al: Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in
inflammatory processes of human cardiovascular pathology. Histochem
Cell Biol. 126:335–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakashima T, Yokoyama A, Onari Y, et al:
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation
and fibrosis. J Allergy Clin Immunol. 121:1269–1276. 2008.
View Article : Google Scholar : PubMed/NCBI
|
